We are live on ! Find out more
SI

Scharf Investments Portfolio holdings

AUM $3.03B
1-Year Est. Return 7.75%
This Fund
S&P 500
This Quarter Est. Return
+6.61%
1 Year Est. Return
+7.75%
3 Year Est. Return
+55.03%
5 Year Est. Return
+80.17%
10 Year Est. Return
+289.59%
AUM
$2.89B
AUM Growth
+$234M
Cap. Flow
+$65M
Cap. Flow %
2.25%
Top 10 Hldgs %
56.28%
Holding
50
New
3
Increased
33
Reduced
14
Closed

Top Buys

Rank Stock Value
1
MAS icon
Masco
MAS
+$57.4M
2
CTSH icon
Cognizant
CTSH
+$37.5M
3
CNC icon
Centene
CNC
+$20.5M
4
VVV icon
Valvoline
VVV
+$16.2M
5
MKL icon
Markel Group
MKL
+$15.3M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$53.8M
2
PGR icon
Progressive
PGR
+$16.6M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$15.4M
4
BKNG icon
Booking.com
BKNG
+$15.2M
5
MSFT icon
Microsoft
MSFT
+$11.2M

Sector Composition

Rank Sector Weight
1 Healthcare 28.48%
2 Technology 17.41%
3 Financials 14.95%
4 Industrials 14.57%
5 Communication Services 12.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.45T
$239M 8.28%
1,014,283
-48,280
-5% -$11.2M
BRK.B icon
2
Berkshire Hathaway Class B
BRK.B
$1.1T
$195M 6.75%
763,321
+4,191
+0.6% +$1.02M
CMCSA icon
3
Comcast
CMCSA
$85B
$168M 5.8%
3,099,449
+14,507
+0.5% +$766K
MCK icon
4
McKesson
MCK
$100B
$162M 5.6%
829,545
-7,672
-0.9% -$1.4M
AAP icon
5
Advance Auto Parts
AAP
$3.35B
$151M 5.23%
823,426
+64,274
+8% +$10.8M
KSU
6
DELISTED
Kansas City Southern
KSU
$150M 5.2%
569,779
-12,658
-2% -$2.75M
ORCL icon
7
Oracle
ORCL
$374B
$145M 5.04%
2,073,293
+16,866
+0.8% +$1.09M
CVS icon
8
CVS Health
CVS
$133B
$145M 5.02%
1,926,154
-6,644
-0.3% -$484K
MKL icon
9
Markel Group
MKL
$23.3B
$141M 4.9%
124,125
+14,176
+13% +$15.3M
LMT icon
10
Lockheed Martin
LMT
$134B
$129M 4.47%
349,606
+41,744
+14% +$14.3M
CNC icon
11
Centene
CNC
$30.7B
$124M 4.28%
1,935,384
+330,437
+21% +$20.5M
JNJ icon
12
Johnson & Johnson
JNJ
$618B
$121M 4.2%
738,982
-203
-0% -$32.8K
LBRDK icon
13
Liberty Broadband Class C
LBRDK
$4.88B
$121M 4.17%
802,707
+59,955
+8% +$9.07M
CTSH icon
14
Cognizant
CTSH
$24.9B
$112M 3.86%
1,427,739
+485,919
+52% +$37.5M
NVS icon
15
Novartis
NVS
$297B
$103M 3.56%
1,204,700
+7,161
+0.6% +$643K
VVV icon
16
Valvoline
VVV
$4.9B
$100M 3.47%
3,846,028
+647,631
+20% +$16.2M
UL icon
17
Unilever
UL
$137B
$95.8M 3.32%
1,525,991
+7,768
+0.5% +$495K
PGR icon
18
Progressive
PGR
$123B
$92.3M 3.2%
965,545
-182,307
-16% -$16.6M
DGX icon
19
Quest Diagnostics
DGX
$25.7B
$83.1M 2.88%
647,377
-3,967
-0.6% -$489K
ALXN
20
DELISTED
Alexion Pharmaceuticals
ALXN
$82.8M 2.87%
541,659
+2,900
+0.5% +$449K
MAS icon
21
Masco
MAS
$14.1B
$61.6M 2.13%
+1,028,216
New +$57.4M
BIDU icon
22
Baidu
BIDU
$37.7B
$58.8M 2.04%
270,254
-206,232
-43% -$53.8M
J icon
23
Jacobs Solutions
J
$15.9B
$49.7M 1.72%
464,637
-2,903
-0.6% -$277K
OTIS icon
24
Otis Worldwide
OTIS
$27.4B
$30M 1.04%
438,695
-59,226
-12% -$3.87M
SPY icon
25
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$7.29M 0.25%
18,405
-40,033
-69% -$15.4M

Similar funds

Scharf Investments's Q1 2021 Portfolio in Review

As of Q1 2021, Scharf Investments held 50 positions worth $2.89B, up 8.8% from $2.66B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Scharf Investments's Q1 2021 filing shows 3 new, 33 increased and 14 reduced positions. Its largest new stake was Masco: 1,028,216 shares worth $61.6M. The largest sale was Baidu, an estimated $53.8M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 29% a quarter earlier, followed by Technology and Financials.

  • Scharf Investments's largest Q1 2021 buy was Masco: 1,028,216 shares worth $61.6M.
  • Scharf Investments added most to Cognizant in Q1 2021, an estimated $37.5M increase.
  • Scharf Investments's biggest Q1 2021 reduction was Baidu, cutting an estimated $53.8M.
  • Scharf Investments's ten largest holdings make up 56% of its $2.89B portfolio in Q1 2021.
  • Scharf Investments opened 3 new positions and closed 0 in Q1 2021.
  • Scharf Investments's portfolio value rose 8.8% quarter-over-quarter to $2.89B.

Based on Scharf Investments's 13F filing for Q1 2021, filed 14 Apr 2021.